References
- Bennet NT, Schultz GS. Growth factors and wound healing: part II. Role in normal and chronic wound healing. Am J 5urg1993; 166: 74–81.
- Buckley A, Davidson JM, Kamerath CD, Woodward SC. Epidermal growth factor in-creases granulation tissue formation dose dependently. J Surg Res1987; 43: 322–328.
- Casu B. Structural and biological activity of heparin. Adv Carbohydr Chem Biochem1985; 43: 51–154.
- Cavari S, Ruggiero M. Antiproliferative effects of heparin on normal and transformed NIH/3T3 fibroblasts. Cell Biol Int1993; 17: 781–786.
- Cook PW, Pittelkow MR, Shipley GD. Growth factor-independent proliferation of normal hu-man neonatal keratinocytes: production of auto-crine- and paracrine-acting mitogenic factors. J Cell Physio11991; 146: 277–289.
- Fager G, Hansson GK, Ottosson P. Dahlhif B, Bondjers G. Human arterial smooth muscle cells in culture. Effects of platelet-derived growth factor and heparin on growth in vitro. Exp Cell Res1988; 176: 319–335.
- Flint N, Cove FL, Evans GS. Heparin stimulates the proliferation of intestinal epithelial cells in primary culture. J Cell Sci1994; 107: 401–411.
- Gilchrest BA, Karassik RL, Wilkins LM. Auto-crine and paracrine growth stimulation of cells derived from human skin. J Cell Physio11983; 117: 235–240.
- Gospodarowicz D, Cheng J. Heparin protects basic and acidic FGF from inactivation. J Cell Physio11986; 128: 475–484.
- Hellström S, Spandow 0. Exogenous heparin, topically administered, aids the remodelling of connective tissue in the healing of experimental tympanic membrane perforations. 0RL1994; 56: 45–50.
- Knighton DR, Ciresi K, Fiegel VD, Schumerth S, Butler E, Cerra F. Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet1990; 170: 56–60.
- Kratz G, Amander C, Swedenborg J et al. Heparin-chitosan complexes stimulate wound healing in human skin. Scand J Plast Reconstr Surg Hand Surg1997; 31: 119–123.
- Kratz G, Lake M, Gidlund M. Insulin like growth factor-1 and -2 and their role in the re-epithelialisation of wounds; interactions with insulin like growth factor binding protein type 1. Scand J Plast Reconstr Surg Hand Surg1994; 28: 107–112.
- Ljungqvist U, Zederfeldt B. The effect of high viscous dextran and heparin on wound healing. Acta Chir Scand1968; 134: 321–325.
- Maurer AM, Han ZC, Dhermy D, Briere TJ. Glycosaminoglycans enhance human leukemic cell growth in vitro. Leuk Res1994; 18: 837–842.
- McPherson J, Ledger P, Ksander G et al. The influence of heparin on the wound healing response to collagen implants in vivo. Collagen and Related Research1988; 8: 83–100.
- Mustoe TA, Pierce GF, Thomason A, Gramates P. Sporn MB, Deuel TF. Accelerated healing of incisional wounds in rats induced by transform-ing growth factor type-f3. Science1987; 237: 1333–1336.
- Robson MC, Phillips LG, Thomason A, Robson LE, Pierce GF. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet1992; 339: 23–25.
- Scheel G, Rahfoth B, Franke J, Grau P. Acceleration of wound healing by local applica-tion of fibronectin. Arch Orthop Trauma Surg1991; 110: 284–287.
- Thompson R, Ludewig R, Wangensteen SL, Rudolf LM. Effects of heparin on wound healing. Surg Gynecol Obstet1971; 134: 22–26.
- Tokura S. Structure and chemical modification of chitin and chitosan. In: Skjak-Braek G, Anthonsen T, Sandford PA, eds. Chitin and chitosan. Amsterdam: Elsevier,1989: 45–50.
- Zhou F, H66k T, Thompson JA, H66k M. Heparin and protein interactions. In: Lane DA, ed. Heparin and related polysaccharides. New York: Plenum Press,1992: 141–153.